NIH-funded research R01 grant

Using artificial intelligence to improve melanoma diagnosis

Official title: Practical Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL)

Funded at Sloan-Kettering Inst Can Research · NIH-11133995 · Data updated 2026-11-12

This study is looking at how artificial intelligence can help doctors diagnose melanoma more accurately, so fewer people need unnecessary skin biopsies, which could lead to better and faster care for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research
NIH-funded
Lab location1 site (New York, United States)
Project startMarch 11, 2025
Project endFebruary 28, 2030
Funding year2025
Award (this year)$700,611
NIH project number1R01CA293974-01A1
Project IDNIH-11133995 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have suspicious skin lesions that may require biopsy for melanoma diagnosis.

Less likely to help

Patients with confirmed melanoma or those who do not have any suspicious skin lesions may not benefit from this research.

What this research studies

This research investigates how artificial intelligence (AI) can assist in the diagnosis of melanoma, aiming to reduce the number of unnecessary skin biopsies while maintaining accurate detection rates. By analyzing clinician surveys and implementing AI algorithms in real-world settings, the study seeks to identify both the benefits and challenges of adopting this technology in clinical practice. The goal is to enhance the diagnostic process and ultimately improve patient outcomes through early detection of melanoma.

Why it matters

Potential benefit: If successful, this research could lead to more accurate melanoma diagnoses, reducing unnecessary procedures and improving patient care.

How similar studies have gone: Preliminary studies at renowned institutions have shown promise in using AI for melanoma diagnosis, indicating potential for success in this approach.

Where this research is happening

  • Sloan-Kettering Inst Can Research
    New York, United States
    Active

Researchers

  • Principal investigator: Rotemberg, Veronica Miriam — Sloan-Kettering Inst Can Research
  • Study coordinator: Rotemberg, Veronica Miriam

Related research

Other NIH-funded projects on the same topics.

  • AI help for early melanoma detection

    This project uses an AI second opinion alongside clinicians to lower unnecessary skin biopsies while keeping melanoma detection high for people with suspicious skin lesions.

    NIH research Sloan-Kettering Inst Can Research · New York, United States · NIH-11301007

  • Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure

    A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.

    NIH research Pennsylvania State Univ Hershey Med Ctr · Hershey, United States · NIH-11635771

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

  • Shorter antifungal treatment for kids with candidemia

    A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606531

  • Shorter antifungal treatment for kids with candidemia

    This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606505

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.